
Metronidazole (1% w/w) + Sucralfate (7% w/w) + Lidocaine (4% w/w)
Active composition
+2 more active ingredients
Metronidazole disrupts DNA synthesis in anaerobic bacteria and protozoa, leading to their death.
Sucralfate forms a viscous gel that adheres to ulcer sites, protecting them from gastric acid and promoting healing.
Lidocaine blocks sodium channels in nerve membranes, preventing the initiation and conduction of nerve impulses.
Medical applications
Meetgyl-ANO Cream is a topical formulation combining Lidocaine (4% w/w), Metronidazole (1% w/w), and Sucralfate (7% w/w), designed for the management of anorectal disorders characterized by pain, inflammation, and infection. Lidocaine, a local anesthetic, provides rapid symptomatic relief by blocking nerve conduction, thereby alleviating pain and discomfort associated with conditions such as hemorrhoids, anal fissures, and post-anal surgery. Metronidazole, an effective nitroimidazole antimicrobial agent, targets anaerobic bacteria and protozoa, reducing local infection and inflammation. Sucralfate acts as a cytoprotective agent, forming a protective barrier over ulcerated or inflamed mucosa, promoting tissue healing and reducing irritation. The synergistic combination of these agents in Meetgyl-ANO Cream facilitates comprehensive management by addressing pain, infection, and mucosal repair concurrently. This formulation is intended for topical application to the affected anorectal area, ensuring localized action with minimal systemic absorption. It is suitable for adult patients requiring symptomatic relief and infection control in anorectal conditions. Usage should follow medical advice, with attention to contraindications such as hypersensitivity to any component. Regular application as prescribed enhances therapeutic outcomes, improving patient comfort and accelerating recovery.
How to use Meetgyl-ANO Rectal Cream This medicine is for external use only. Use it in the dose and duration as advised by your doctor.
Important precautions
Based on clinical trials and patient reports.
Overall Tolerance
Common Side Effects
No interaction found/established
High Risk
Information regarding the use of Meetgyl-ANO Cream during pregnancy is not available. Please consult your doctor.
Medical Advice
No interaction found/established
Exercise Caution
There is limited information available on the use of Meetgyl-ANO Cream in patients with liver disease. Please consult your doctor.
Regular Checkup
Information regarding the use of Meetgyl-ANO Cream during breastfeeding is not available. Please consult your doctor.
Consult Doctor
There is limited information available on the use of Meetgyl-ANO Cream in patients with kidney disease. Please consult your doctor.
Regular Checkup
0 reviews for Meetgyl-ANO Cream

Lidocaine (4% w/w) + Metronidazole (1% w/w) + Sucralfate (7% w/w)
Cheaper alternative availability
This medicine doesn't have a cheaper alternative with the same composition. Our health advisors can help you find other savings options based on your prescription.
Active composition
+2 more active ingredients
Metronidazole disrupts DNA synthesis in anaerobic bacteria and protozoa, leading to their death.
Sucralfate forms a viscous gel that adheres to ulcer sites, protecting them from gastric acid and promoting healing.
Lidocaine blocks sodium channels in nerve membranes, preventing the initiation and conduction of nerve impulses.
Medical applications
Meetgyl-ANO Cream is a topical formulation combining Lidocaine (4% w/w), Metronidazole (1% w/w), and Sucralfate (7% w/w), designed for the management of anorectal disorders characterized by pain, inflammation, and infection. Lidocaine, a local anesthetic, provides rapid symptomatic relief by blocking nerve conduction, thereby alleviating pain and discomfort associated with conditions such as hemorrhoids, anal fissures, and post-anal surgery. Metronidazole, an effective nitroimidazole antimicrobial agent, targets anaerobic bacteria and protozoa, reducing local infection and inflammation. Sucralfate acts as a cytoprotective agent, forming a protective barrier over ulcerated or inflamed mucosa, promoting tissue healing and reducing irritation. The synergistic combination of these agents in Meetgyl-ANO Cream facilitates comprehensive management by addressing pain, infection, and mucosal repair concurrently. This formulation is intended for topical application to the affected anorectal area, ensuring localized action with minimal systemic absorption. It is suitable for adult patients requiring symptomatic relief and infection control in anorectal conditions. Usage should follow medical advice, with attention to contraindications such as hypersensitivity to any component. Regular application as prescribed enhances therapeutic outcomes, improving patient comfort and accelerating recovery.
How to use Meetgyl-ANO Rectal Cream This medicine is for external use only. Use it in the dose and duration as advised by your doctor.
Important precautions
Based on clinical trials and patient reports.
Overall Tolerance
Common Side Effects
No interaction found/established
High Risk
Information regarding the use of Meetgyl-ANO Cream during pregnancy is not available. Please consult your doctor.
Medical Advice
No interaction found/established
Exercise Caution
There is limited information available on the use of Meetgyl-ANO Cream in patients with liver disease. Please consult your doctor.
Regular Checkup
Information regarding the use of Meetgyl-ANO Cream during breastfeeding is not available. Please consult your doctor.
Consult Doctor
There is limited information available on the use of Meetgyl-ANO Cream in patients with kidney disease. Please consult your doctor.
Regular Checkup
0 reviews for Meetgyl-ANO Cream















